Advertisement Bayer Schering Pharma names new chairman - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Bayer Schering Pharma names new chairman

Bayer Schering Pharma has appointed Andreas Fibig, currently a senior vice president at Pfizer, as chairman of the board of management, effective September 1, 2008.

In addition, Bernd Metzner, currently head of finance at Bayer SpA, Italy, will assume responsibility for central administration and organization (CAO) at Bayer Schering Pharma (BSP) effective October 1, 2008.

In this context, Arthur Higgins, the current chairman of the board of management of BSP, and Werner Baumann, current CAO head for BSP, will return to focusing on their primary roles as chairman and CEO of the Bayer HealthCare (BHC) subgroup and head of BHC CAO respectively. Both Higgins and Baumann have performed dual functions at BHC and BSP since Bayer’s acquisition of the former Schering AG in 2006.

In the future, Arthur Higgins will focus on leading Bayer HealthCare and driving the company forward. In addition to Bayer Schering Pharma, this Bayer subgroup also comprises the animal health, consumer care and diabetes care divisions.

Mr Higgins said: “The appointments of Andreas Fibig as the new head of the global pharmaceuticals business and of Bernd Metzner as a new member of the BSP board of management add two excellent managers to our leadership team.”